Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Obesity and cardiometabolic risk
Graphical Abstract Similar content being viewed by others Introduction Non-alcoholic fatty liver disease (NAFLD) is considered to be the hepatic manifestation of the metabolic syndrome, which is believed to affect approximately 25% of adults worldwide and more than half of individuals with type 2 diabetes mellitus [1]
Diabetes Australia
The Role of Semaglutide in Managing Blood Sugar Semaglutide was first developed to help people with type 2 diabetes manage their blood sugar levels
MicroRNA: Biogenesis, Function and Role in Cancer
US$ 20.27
US$ 25.42
US$ 24.22
US$ 23.21
